SLEEP MEDICINE

The Founder and CEO of NeuroTrials Research spoke about the current landscape of insomnia, noting that lemborexant holds promise as a potential therapy.
The associate professor at NYU Langone discussed several of the questions that remained unanswered about the relationship between sleep and Alzheimer disease.

About NeurologyLive's Sleep Medicine Clinical Focus page:

Content found within NeurologyLive's Sleep Medicine Clinical Focus page offers the latest and most valuable information on emerging therapies for sleep disturbances and disorders. Articles include relevant updates from the floor of the most notable neurology conferences and annual meetings, as well as video interviews with the leading experts in neurology, especially those specializing in the treatment of narcolepsy and obstructive sleep apnea.
 
A lack of sleep has proven to be damaging to physical, mental, and emotional health, and the content offered on this page, which includes breaking news coverage of approvals from the U.S. Food and Drug Administration (FDA), key takeaways from recent clinical trials of new and emerging therapies, and notifications of updates to clinical guidelines, is intended to dramatically improve patient care.